发明名称 INHALABLE AZTREONAM LYSINATE FORMULATION FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
摘要 A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam lysinate delivered as an aerosol or dry powder formulation.
申请公布号 US2017014389(A1) 申请公布日期 2017.01.19
申请号 US201615132826 申请日期 2016.04.19
申请人 Gilead Sciences, Inc. 发明人 Montgomery Alan B.
分类号 A61K31/427;A61K9/00 主分类号 A61K31/427
代理机构 代理人
主权项
地址 Foster City CA US